# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-067464
Filing Date
2026-02-24
Accepted
2026-02-24 17:07:45
Documents
77
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | crdf-20251231.htm iXBRL | 10-K | 2694914
2 | EX-10.15 | crdf-ex10_15.htm | EX-10.15 | 186297
3 | EX-23.1 | crdf-ex23_1.htm | EX-23.1 | 3712
4 | EX-31.1 | crdf-ex31_1.htm | EX-31.1 | 14562
5 | EX-31.2 | crdf-ex31_2.htm | EX-31.2 | 14448
6 | EX-32.1 | crdf-ex32_1.htm | EX-32.1 | 8642
7 | EX-32.2 | crdf-ex32_2.htm | EX-32.2 | 8521
8 | GRAPHIC | img3640904_0.gif | GRAPHIC | 8550
| Complete submission text file | 0001193125-26-067464.txt |  | 11477766

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | crdf-20251231.xsd | EX-101.SCH | 1209089
79 | EXTRACTED XBRL INSTANCE DOCUMENT | crdf-20251231_htm.xml | XML | 2490097

Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35558 | Film No.: 26672837
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)